Literature DB >> 27407342

OVARIAN HYPERSTIMULATION SYNDROME DURING INDUCTION OF OVULATION FOR INTRA UTERINE INSEMINATION.

S K Rath1, R K Sharma1, P Tarneja2, A B Chattopadhyay3, R D Wadhwa1.   

Abstract

Ovarian Hyperstimulation Syndrome (OHSS) is a known iatrogenic complication of ovulation induction. Our experience of such complication while managing basic assisted conception cycles has been analysed in the present study. 12 such cases were identified in 976 cycles studied giving an overall incidence of 1.22%. All the cases were of mild to moderate variety and were managed conservatively. The duration of the complication ranged between 10 days to 6 weeks. Polycystic ovarian disease, LH: FSH ratio of more than 1, presence of four or more secondary follicles were found to be important predictive criteria. Identification of predictive factors of OHSS can be helpful in taking due care while using ovulation inducing drugs. Conception does worsen OHSS, but termination is usually not necessary.

Entities:  

Keywords:  OHSS; Ovulation Induction

Year:  2011        PMID: 27407342      PMCID: PMC4925111          DOI: 10.1016/S0377-1237(01)80045-9

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  10 in total

Review 1.  Ovarian hyperstimulation syndrome: an update review.

Authors:  A Golan; R Ron-el; A Herman; Y Soffer; Z Weinraub; E Caspi
Journal:  Obstet Gynecol Surv       Date:  1989-06       Impact factor: 2.347

2.  LH/FSH ratio as a predictor of ovarian hyperstimulation syndrome.

Authors:  J Bódis; A Török; H R Tinneberg
Journal:  Hum Reprod       Date:  1997-04       Impact factor: 6.918

3.  Prediction of ovarian hyperstimulation syndrome by ultrasound volumetric assessment [corrected] of baseline ovarian volume prior to stimulation.

Authors:  B Danninger; M Brunner; A Obruca; W Feichtinger
Journal:  Hum Reprod       Date:  1996-08       Impact factor: 6.918

Review 4.  Ovarian hyperstimulation syndrome: a current survey.

Authors:  J G Schenker; D Weinstein
Journal:  Fertil Steril       Date:  1978-09       Impact factor: 7.329

Review 5.  Complications of assisted reproductive techniques.

Authors:  J G Schenker; Y Ezra
Journal:  Fertil Steril       Date:  1994-03       Impact factor: 7.329

6.  Human menopausal gonadotropins for anovulation and sterility. Results of 7 years of treatment.

Authors:  E Rabau; A David; D M Serr; S Mashiach; B Lunenfeld
Journal:  Am J Obstet Gynecol       Date:  1967-05-01       Impact factor: 8.661

7.  Heterotopic pregnancies after in vitro fertilization and embryo transfer.

Authors:  B Rizk; S L Tan; S Morcos; A Riddle; P Brinsden; B A Mason; R G Edwards
Journal:  Am J Obstet Gynecol       Date:  1991-01       Impact factor: 8.661

8.  Ultrasonographic and clinical correlates of menotropin versus sequential clomiphene citrate: menotropin therapy for induction of ovulation.

Authors:  J Tal; B Paz; I Samberg; N Lazarov; M Sharf
Journal:  Fertil Steril       Date:  1985-09       Impact factor: 7.329

9.  Androstenedione as a predictor of ovarian hyperstimulation syndrome.

Authors:  O Gustafson; K Carlström; L Nylund
Journal:  Hum Reprod       Date:  1992-08       Impact factor: 6.918

10.  Plasma estradiol is superior to ultrasound and urinary estriol glucuronide as a predictor of ovarian hyperstimulation during induction of ovulation with menotropins.

Authors:  R V Haning; C W Austin; I H Carlson; D L Kuzma; S S Shapiro; W J Zweibel
Journal:  Fertil Steril       Date:  1983-07       Impact factor: 7.329

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.